Morning Star | Eight Qiming Venture Partners Portfolio Companies Named to QbitAI Research Institute's 2025Q3 AI 100 Product Rankings
The flagship product list represents the leading players in the current landscape, while the innovation product list spotlights the seed candidates poised for future markets. Together, these two lists — spanning from comprehensive strength to breakthrough potential — sketch out a more three-dimensional and authentic map of AI products, offering industry participants and observers a set of reference-worthy benchmarks.
Recently, QbitAI Think Tank released the 2025 Q3 AI 100 Product Dual Rankings. This selection comprises two lists — a flagship product ranking and an innovation product ranking. The former represents the current leading cohort, while the latter spotlights future market contenders. Together, these two rankings paint a more multidimensional and authentic map of AI products, offering reference points for industry participants and observers alike.
Qiming Venture Partners portfolio companies Zhipu AI, StepFun, Meitu (01357.HK), Xiaomi (01810.HK), and Future Intelligent were named to the 2025 Q3 AI 100 Flagship Product Ranking; StepFun, Shengshu Technology, and Mafengwo were named to the 2025 Q3 AI 100 Innovation Product Ranking.
Zhipu AI
(Zhipu Qingyan, Z.AI)
StepFun
(Step AI)
Meitu
(RoboNeo, Meitu Design Studio, Meitu Xiuxiu)
Xiaomi
(Xiaomi AI Glasses)
Future Intelligent
(iFLYBUDS Pro3)
Named to the
2025 Q3 AI 100 Flagship Product Ranking
StepFun
(Step AI Desktop Companion)
Shengshu Technology
(Vidu)
Mafengwo
(Mafengwo AI Travel Itinerary)
Named to the
2025 Q3 AI 100 Innovation Product Ranking
Selection Criteria
· QbitAI Think Tank 2025 Q3 AI 100 Product Dual Rankings
QbitAI Think Tank employed a dual evaluation system combining quantitative and qualitative metrics. On the quantitative side, real user data formed the foundation, covering four core dimensions — user scale, user growth, user activity, and user stickiness — with over 20 specific indicators including total downloads, new downloads, active users, and retention rates. On the qualitative side, the focus was on long-term growth potential, with expert assessments and user research evaluating underlying technology, market opportunity, product design, monetization potential, team background, and growth velocity.
QbitAI Think Tank noted that the present moment — when users are voting with new workflows and repeat purchases — may well be the period of greatest competition and unpredictability for AI products. Faced with almost entirely new functional logic in the AI era (such as uncertain product deliverables), design philosophy (task completion as the core, rather than ecosystem traffic), and user psychology (lower switching costs, willingness to experiment with entirely new workflows), all players — whether established giants with a head start or a new generation of entrepreneurs born in this era — still need to feel their way forward. How to thoroughly and effectively address specific scenarios and pain points along users' core usage journeys will be the central proposition for the next phase. For now, "scenario segmentation" and "hyper-personalization" may be the certainty within current uncertainty.
Source | QbitAI Think Tank
P A S T H I G H L I G H T S
Qiming Stars | 7 Qiming Venture Partners Portfolio Companies Named to QbitAI Think Tank 2025 H1 AI 100 Product Dual Rankings Qiming Stars | WeRide and Cornerstone Robotics Named to 2025 Wealth China Best Design Rankings Qiming Honors | Qiming Venture Partners Wins Three Awards Including China Venture Capital Research Institute 2025 China Venture Capital Industry Annual Golden Investment Award
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early and growth-stage companies in Technology and Healthcare.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many Qiming Venture Partners portfolio companies have grown into the most influential companies in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ: BILI, 09626.HK), Zhihu (NYSE: ZH, 02390.HK), Roborock (688169.SH), Hesai Technology (NASDAQ: HSAI, 02525.HK), UBTECH (09880.HK), WeRide (NASDAQ: WRD, 00800.HK), HyperStrong (688411.SH), Insta360 (688775.SH), Unisound (09678.HK), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ: ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ: SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), SinoCellTech (688520.SH), Apros Therapeutics, Yuanxin Technology, Insilico Medicine, MediLink Therapeutics, LaNova Medicines, Zhipu AI, StepFun, Biren Technology, and others.